Kristina Callis Duffin, M.D

Assistant Professor in Dermatology

B.S., 1989, Montana State University
M.D., 1993, University of Washington School of Medicine
Residency in Internal Medicine, 1994-1997, Maine Medical Center Clinical Research Fellowship in Dermatology, 2000-2002, University of Utah
Residency in Dermatology, 2002-2005, University of Utah
Board Certification in Internal Medicine and Dermatology

Clinical and Research Interests
Dr. Duffin’s principal clinical interests are General Dermatology and Psoriasis. Her research interests include Psoriasis: Clinical Trials and the Genetics of Psoriasis.

She is the Co-Director of the Utah Psoriasis Initiative.

Selected Publications
Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007 Feb;80(2):273-90.

Christensen TE, Callis KP, Papenfuss J, Hoffman MS, Hansen CB, Wong B, Panko JM, Krueger GG. Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes. J Invest Dermatol. 2006 Nov;126(11):2397-403.

Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, Krueger GG. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005 Dec;141(12):1527-34.

Krueger GG, Callis KP. Development and use of alefacept to treat psoriasis. J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S87-97. Review.

Carlin CS, Callis KP, Krueger GG. Efficacy of acitretin and commercial tanning bed therapy for psoriasis. Arch Dermatol. 2003 Apr;139(4):436-42.